Could Acadia use the p1 results from Neuren for Fragike X though - it would make sense from a safety perspective, but if that was the case then Neuren wouldn’t need to run any additional p1 trials fir the 3 additional indications they are running now, unless the dosage is different, but I don’t think it is…
Could Acadia use the p1 results from Neuren for Fragike X though...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.51 |
Change
-0.480(2.40%) |
Mkt cap ! $2.505B | |||
| Open | High | Low | Value | Volume |
| $20.10 | $20.10 | $19.40 | $1.681M | 85.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 357 | $19.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.53 | 127 | 6 |
View Market Depth
| Last trade - 11.22am 09/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |